Latest debt-to-equity ratio

Lakefront Biotherapeutics Debt-to-equity ratio

Direct answer

Lakefront Biotherapeutics's debt-to-equity ratio is 0.2%.

The verified market snapshot reports 0.2%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.

Get free Lakefront Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
0.2%